Rafael Holdings Inc RFL:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/15/24 EDT
1.56quote price arrow down-0.03 (-1.89%)
Volume
21,169
52 week range
1.44 - 2.52
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.56
  • 52 Week High2.52
  • 52 Week High Date08/08/23
  • 52 Week Low1.44
  • 52 Week Low Date10/26/23

Key Stats

  • Market Cap38.352M
  • Shares Out24.58M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta1.32
  • YTD % Change-14.75

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.56
  • 52 Week High2.52
  • 52 Week High Date08/08/23
  • 52 Week Low1.44
  • 52 Week Low Date10/26/23
  • Market Cap38.352M
  • Shares Out24.58M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta1.32
  • YTD % Change-14.75

RATIOS/PROFITABILITY

  • EPS (TTM)0.09
  • P/E (TTM)17.16
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-11.171M
  • ROE (TTM)2.20%
  • Revenue (TTM)275,000.006
  • Gross Margin (TTM)-
  • Net Margin (TTM)921.82%
  • Debt To Equity (MRQ)1.62%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Rafael Holdings Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Rafael Holdings, Inc. is a holding company with interests in clinical and early-stage pharmaceutical companies. The Company's segments include healthcare and real estate. The Company's investments include Cornerstone Pharmaceuticals, Inc., which is a cancer metabolism-based therapeutics company; LipoMedix Pharmaceuticals Ltd., which is a clinical-stage pharmaceutical company; Barer Institute Inc., which is a preclinical cancer metabolism research operation; Cyclo Therapeutics...
Howard Jonas
Executive Chairman of the Board
William Conkling
President, Chief Executive Officer
David Polinsky
Chief Financial Officer
Address
520 Broad St
Newark, NJ
07120
United States